Vascular Disease and Thrombosis

Loading the player...

VOYAGER PAD | Marc Bonaca, MD, MPH

Investigator Marc Bonaca, MD, MPH reports the results of the VOYAGER PAD trial, which examined reducing the risk of adverse limb and cardiovascular outcomes in patients with lower extremity PAD after intervention. See this study and other late-breaking science presentations on our AHA Science News from ACC 2020 page.

Science NewsView All Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with und...
Venous Thromboembolism Research Priorities
07/08/2020 | Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the U.S. and worldwide.
AHA Journals This Week | July 6, 2020
07/06/2020 | AHA Journals This Week July 6, 2020
Impact Your Practice with Scientific Sessions OnDemand(tm) Vascular Disease and Thrombosis Track Available Now!
Brain Illustration_280x215

Vascular Cognitive Impairment

This online course provides the most current and comprehensive scope of knowledge in the early assessment and management of vascular cognitive impairment. The presentations from experts in the field will challenge and expand on contemporary patient care across the age continuum. Register Today!

Related Councils

Council on Peripheral Vascular Disease (PVD)

Naomi Hamburg, MD, MS, FAHA

The Council on Peripheral Vascular Disease (PVD) is a vibrant, interdisciplinary council whose members are focused on improving the care of patients with vascular diseases through advancing science, education, advocacy, and improved healthcare delivery. To achieve our goals within the American Heart Association we need to continue to grow our membership and foster their active involvement in all of our educational programs and scientific initiatives. This means we need you!

Naomi Hamburg, MD, MS, FAHA
Chair, Council on Peripheral Vascular Disease

Vascular Discovery Scientific Sessions       Circulation       PVD Council Awards

Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB)

Kerry-Anne Rye, PhD, FAHA

The Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) contributes to the mission and objectives of the American Heart Association (AHA) through efforts in the fields of arteriosclerosis, thrombosis and vascular biology. The council advances and coordinates research, addresses prevention, improves methods for diagnosis and treatment, and works actively with other organizations concerned with these issues. The council disseminates reliable information related to these fields through its annual conference, many awards and lectures, and the AHA's journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Kerry-Anne Rye, PhD, FAHA
Chair, Council on Arteriosclerosis, Thrombosis and Vascular Biology

Vascular Discovery Scientific Sessions       Arteriosclerosis, Thrombosis, and Vascular Biology       ATVB Council Awards

Council on Clinical Cardiology (CLCD)

Eldrin Lewis, MD, MPH, FAHA, FACC

The purpose of the Council on Clinical Cardiology (CLCD) is to achieve the objectives of the American Heart Association (AHA) in the field of clinical cardiology, to promote excellence in clinical care and to foster the professional development and education of clinical cardiologists. Through council-sponsored symposia, panels and scientific conferences, members can access new developments in the field and interpret and promote clinical cardiology to professional and lay audiences.

Eldrin Lewis, MD, MPH, FAHA, FACC
Chair, Council on Clinical Cardiology

Scientific Sessions       Circulation       CLCD Council Awards

Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR)

Fumito Ichinose, MD, PhD, FAHA

The American Heart Association's (AHA) strategic goal to reduce coronary heart disease, stroke and risk by 20 percent by the year 2020 has led to an emphasis on the importance of resuscitation and the chain of survival in AHA activities and use of resources. The Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation (3CPR) bench-to-bedside and community approach ranges from integrated cardiopulmonary physiology to issues of critical care, emergency cardiovascular care and CPR. Pulmonary hypertension and regulation of the pulmonary circulation have historically been areas of investigation for many of our council members. The council is keenly interested in promoting approaches that include clinical care, clinical research and basic science.

This is an exciting time for the 3CPR Council; the past few years have seen growth in our membership and new programs, including the formation of a robust Early Career Committee and inclusion of pre-hospital providers into our activities and programming.

Fumito Ichinose, MD, PhD, FAHA
Chair, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation

Resuscitation Science Symposium       Scientific Sessions       Circulation       3CPR Council Awards